Cited by 471Inflammatory Bowel DiseaseMicrobial Metabolites in Food BiotechnologyGut microbiota and health

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

Open access

Lindsay, J O·2006·Gut

DOI 10.1136/gut.2005.074971PMC PMC1856087

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND AND AIMS: The intestinal microbiota play a pivotal role in the inflammation associated with Crohn's disease through their interaction with the mucosal immune system. Some bifidobacteria species are immunoregulatory and induce increased dendritic cell interleukin 10 (IL-10) release in vitro. Fructo-oligosaccharides (FOS) increase faecal and mucosal bifidobacteria in healthy volunteers. The aim of this study was to assess the effect of FOS administration on disease activity, bifidobacteria concentrations, and mucosal dendritic cell function in patients with moderately active Crohn's disease. PATIENTS AND METHODS: Ten patients with active ileocolonic Crohn's disease received 15 g of FOS for three weeks. Disease activity was measured using the Harvey Bradshaw index. Faecal and mucosal bifidobacteria were quantified by fluorescence in situ hybridisation, and mucosal dendritic cell IL-10 and Toll-like receptor (TLR) expression were assessed by flow cytometry of dissociated rectal biopsies. RESULTS: FOS induced a significant reduction in the Harvey Bradshaw index from 9.8 (SD 3.1) to 6.9 (3.4) (p<0.01). There was a significant increase in faecal bifidobacteria concentration from 8.8 (0.9) log(10) to 9.4 (0.9) log(10) cells/g dry faeces (p<0.001). The percentage of IL-10 positive dendritic cells increased from 30 (12)% to 53 (10)% (p=0.06). Finally, the percentage of dendritic cells expressing TLR2 and TLR4 increased from 1.7 (1.7)% to 36.8 (15.9)% (p=0.08) and from 3.6 (3.6)% to 75.4 (3.4)% (p<0.001), respectively. CONCLUSIONS: FOS supplementation increases faecal bifidobacteria concentrations and modifies mucosal dendritic cell function. This novel therapeutic strategy appears to decrease Crohn's disease activity in a small open label trial and therefore warrants further investigation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/gut.2005.074971

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations
Amann, R., Binder, B. J., Olson, R. J., Chisholm, S. W., Devereux, R., & Stahl, D. A. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.6.1919-1925.1990 · Cited by 4,049
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,974
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi‐Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,554
Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
Gibson, G. R., Beatty, E. R., Wang, X., & Cummings, J. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90192-2 · Cited by 1,529
Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Mucosal flora in inflammatory bowel disease
Swidsinski, A. V., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V. A., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,344
Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment
Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., & SCHLEIFER, K. H. (1996) · Microbiology · doi:10.1099/13500872-142-5-1097 · Cited by 1,176

Show all 55 references

Research works printed but not linked: 1

Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4 beta7 integrin. Eur J Immunol 2002;32:1445-54.

Sorted by citations

Items 101–200 of 469

Targeting the Gut–Eye Axis: An Emerging Strategy to Face Ocular Diseases
Campagnoli, L. I. M., Varesi, A., Barbieri, A., Marchesi, N., & Pascale, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713338 · Cited by 91
An Update on Prebiotics and on Their Health Effects
Bevilacqua, A., Campaniello, D., Speranza, B., Racioppo, A., Sinigaglia, M., & Corbo, M. R. (2024) · Foods · doi:10.3390/foods13030446 · Cited by 97
Glucomannans and nutrition
Tester, R. F., & Al‐Ghazzewi, F. H. (2016) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2016.05.017 · Cited by 82
Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy
Serban, D. E. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615606898 · Cited by 79
In Vitro Fermentation of Sugar Beet Arabino-Oligosaccharides by Fecal Microbiota Obtained from Patients with Ulcerative Colitis To Selectively Stimulate the Growth of Bifidobacterium spp. and Lactobacillus spp
Vigsnæs, L. K., Holck, J., Meyer, A. S., & Licht, T. R. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05895-11 · Cited by 82
Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation
Andermann, T. M., Rezvani, A. R., & Bhatt, A. S. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0302-9 · Cited by 78
Unraveling the Role of the Human Gut Microbiome in Health and Diseases
Khalil, M., Ciaula, A. D., Mahdi, L., Jaber, N., Palo, D. M. D., Graziani, A., Baffy, G., & Portincasa, P. (2024) · Microorganisms · doi:10.3390/microorganisms12112333 · Cited by 100
Dysbiotic gut microbiome: A key element of Crohn's disease
Øyri, S. F., Műzes, G., & Sípos, F. (2015) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2015.10.005 · Cited by 78
Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial.
García-Peris, P., Velasco, C., Lozano, M. A., Moreno, Y., Paron, L., Cuerda, C., Lesmes, I. B., Camblor, M., García‐Hernández, J., Guarner, F., et al. (2012) · PubMed · doi:10.3305/nh.2012.27.6.5992 · Cited by 73
Studies with Inulin-Type Fructans on Intestinal Infections, Permeability, and Inflammation
Guarner, F. (2007) · Journal of Nutrition · doi:10.1093/jn/137.11.2568s · Cited by 73
Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis
Lara‐Villoslada, F., de Haro, O., Camuesco, D., Comalada, M., Velasco, J., Zarzuelo, A., Xaus, J., & Gálvez, J. (2006) · European Journal of Nutrition · doi:10.1007/s00394-006-0610-2 · Cited by 73
Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients
Matijašić, M., Meštrović, T., Perić, M., Paljetak, H. Č., Panek, M., Bender, D. V., Kelečić, D. L., Krznarić, Ž., & Verbanac, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040578 · Cited by 71
Prebiotics in inflammatory bowel diseases
Guarner, F. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507832958 · Cited by 70
Protective effect of galactooligosaccharide-supplemented enteral nutrition on intestinal barrier function in rats with severe acute pancreatitis
Zhong, Y., Cai, D., Cai, W., Geng, S., Chen, L., & Han, T. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.04.026 · Cited by 69
Intestinal dendritic cells
Ng, S. C., Kamm, M. A., Stagg, A. J., & Knight, S. C. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21247 · Cited by 71
β2-1 Fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: results from a double-blinded, randomised, cross-over study in healthy adults
Clarke, S. T., Green-Johnson, J. M., Brooks, S. P. J., Ramdath, D. D., Berčík, P., Avila, C., Inglis, G. D., Green, J., Yanke, L. J., Selinger, L. B., et al. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516000908 · Cited by 68
Prebiotics in the Gastrointestinal Tract
Macfarlane, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374938-3.00010-4 · Cited by 68
Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation
Madella, A. M., van Bergenhenegouwen, J., Garssen, J., Masereeuw, R., & Overbeek, S. A. (2022) · Toxins · doi:10.3390/toxins14090645 · Cited by 70
The Microbiome in Crohn's Disease
Khanna, S., & Raffals, L. E. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.05.004 · Cited by 75
Bacillus coagulans in Combination with Chitooligosaccharides Regulates Gut Microbiota and Ameliorates the DSS-Induced Colitis in Mice
Liu, Z., Jiang, Z., Zhang, Z., Liu, T., Fan, Y., Liu, T., & Peng, N. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00641-22 · Cited by 67
Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
Berg, D., Clemente, J. C., & Colombel, J. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1013031 · Cited by 65
Clinical Evidence for the Microbiome in Inflammatory Diseases
Slingerland, A. E., Schwabkey, Z. I., Wiesnoski, D. H., & Jenq, R. R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00400 · Cited by 65
Revisiting the Concepts of Prebiotic and Prebiotic Effect in Light of Scientific and Regulatory Progress—A Consensus Paper From the Global Prebiotic Association
Deehan, E. C., Antwan, S. A., Witwer, R. S., Guerra, P. G., John, T., & Monheit, L. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100329 · Cited by 71
Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease
He, P., Yu, L., Tian, F., Zhang, H., Chen, W., & Zhai, Q. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac029 · Cited by 65
Mechanisms and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management of digestive disorders
Whelan, K. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113001262 · Cited by 61
Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists
Cutler, C. W., & Teng, Y.-T. A. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2007.00222.x · Cited by 63
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?
Bringiotti, R. (2014) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v5.i4.550 · Cited by 65
Soluble Extracts from Chia Seed (Salvia hispanica L.) Affect Brush Border Membrane Functionality, Morphology and Intestinal Bacterial Populations In Vivo (Gallus gallus)
da Silva, B. P., Kolba, N., Martino, H. S. D., Hart, & Tako, E. (2019) · Nutrients · doi:10.3390/nu11102457 · Cited by 65
What role do bacteria play in persisting fistula formation in idiopathic and Crohn's anal fistula?
Tozer, P. J., Rayment, N. B., Hart, A. L., Daulatzai, N., Murugananthan, A., Whelan, K., & Phillips, R. K. S. (2014) · Colorectal Disease · doi:10.1111/codi.12810 · Cited by 60
Altered Host-Microbe Interaction in HIV: A Target for Intervention with Pro- and Prebiotics
Hummelen, R., Vos, A. P., Land, B. V., van Norren, K., & Reid, G. (2010) · International Reviews of Immunology · doi:10.3109/08830185.2010.505310 · Cited by 57
The effects of konjac oligosaccharide on TNBS-induced colitis in rats
Liu, R., Li, Y., & Zhang, B. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.040 · Cited by 60
The Current State of Knowledge on Salvia hispanica and Salviae hispanicae semen (Chia Seeds)
Motyka, S., Koc, K., Ekiert, H., Blicharska, E., Czarnek, K., & Szopa, A. (2022) · Molecules · doi:10.3390/molecules27041207 · Cited by 58
Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics
Bilal, M., Ashraf, S., & Zhao, X. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.931458 · Cited by 58
Probiotic and prebiotic use in patients with inflammatory bowel disease
Hedin, C. R. H., Mullard, M., Sharratt, E., Jansen, C., Sanderson, J. D., Shirlaw, P., Howe, L. C., Djemal, S., Stagg, A. J., Lindsay, J. O., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21286 · Cited by 57
Self-citation
Update on the Gastrointestinal Microbiome in Systemic Sclerosis
Bellocchi, C., & Volkmann, E. R. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0758-9 · Cited by 57
Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases
Jadhav, P., Jiang, Y., Jarr, K. J., Layton, C., Ashouri, J. F., & Sinha, S. R. (2020) · Nutrients · doi:10.3390/nu12072156 · Cited by 56
Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling
Jung, C., Meinzer, U., Montcuquet, N., Thachil, É., Château, D., Thiébaut, R., Roy, M., Nabhani, Z. A., Berrebi, D. D., Dussaillant, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58147 · Cited by 55
Impact of Probiotics and Prebiotics on Gut Microbiome and Hormonal Regulation
Basnet, J., Eissa, M., Cardozo, L. L. Y., Romero, D. G., & Rezq, S. (2024) · Gastrointestinal Disorders · doi:10.3390/gidisord6040056 · Cited by 65
Review article: the psychoneuroimmunology of irritable bowel syndrome – an exploration of interactions between psychological, neurological and immunological observations
Arebi, N., Gurmany, S., Bullas, D. C., Hobson, A. R., Stagg, A. J., & Kamm, M. A. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03801.x · Cited by 53
Probiotics and prebiotics in Crohn's disease therapies
Lichtenstein, L., Avni‐Biron, I., & Ben‐Bassat, O. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.002 · Cited by 53
Prebiotics, synbiotics and inflammatory bowel disease
Steed, H., Macfarlane, G. T., & Macfarlane, S. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700139 · Cited by 52
Modulation of PPAR-γby Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases
Ortuño‐Sahagún, D., Márquez-Aguirre, A. L., Quintero-Fabián, S., López-Roa, R. I., & Rojas-Mayorquín, A. E. (2012) · PPAR Research · doi:10.1155/2012/318613 · Cited by 54
Koch's postulates, microbial dysbiosis and inflammatory bowel disease
Singh, V., Proctor, S. D., & Willing, B. P. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.018 · Cited by 55
Mucosal Barrier and Th2 Immune Responses Are Enhanced by Dietary Inulin in Pigs Infected With Trichuris suis
Myhill, L. J., Stolzenbach, S., Hansen, T. V. A., Skovgaard, K., Stensvold, C. R., Andersen, L. O., Nejsum, P. L., Mejer, H., Thamsborg, S. M., & Williams, A. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02557 · Cited by 51
The effect of Faecalibacterium prausnitzii and its extracellular vesicles on the permeability of intestinal epithelial cells and expression of PPARs and ANGPTL4 in the Caco-2 cell culture model
Moosavi, S. M., Sepahi, A. A., Mousavi, S. F., Vaziri, F., & Siadat, S. D. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00605-1 · Cited by 51
Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model
Chen, B., Du, L., He, H., Kim, J. J., Zhao, Y. S., Zhang, Y., Luo, L., & Dai, N. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8321 · Cited by 49
Present and Future Therapeutic Approaches to Barrier Dysfunction
Fortea, M., Albert-Bayo, M., Abril-Gil, M., Mall, J. G., Serra-Ruiz, X., Henao-Paez, A., Expósito, E., González-Castro, A. M., Guagnozzi, D., Lobo, B., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.718093 · Cited by 49
Handbook of Prebiotics and Probiotics Ingredients
Cho, S. S., & Finocchiaro, T. (2009) · CRC Press eBooks · doi:10.1201/9781420062151 · Cited by 49
The Microbiome in Patients With Inflammatory Diseases
Somineni, R. P., & Kugathasan, S. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.078 · Cited by 49
Gut dysbiosis and paediatric Crohn's disease
Brusaferro, A., Cavalli, E., Farinelli, E., Cozzali, R., Principi, N., & Esposito, S. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.10.005 · Cited by 48
Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation
Riwes, M. M., Golob, J. L., Magenau, J. M., Shan, M., Dick, G. J., Braun, T., Schmidt, T. M., Pawarode, A., Anand, S. M., Ghosh, M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02587-y · Cited by 52
Effects of Dietary Interventions on Gut Microbiota in Humans and the Possible Impacts of Foods on Patients’ Responses to Cancer Immunotherapy
Wang, L., Mo, Y. Y., Huang, Y., Echeveste, C. E., Wang, H., Chen, J., Oshima, K., Yearsley, M., Simal‐Gándara, J., Battino, M. A., et al. (2020) · eFood · doi:10.2991/efood.k.200824.002 · Cited by 47
Fructooligosaccharides production and the health benefits of prebiotics
Nobre, C., Simões, L. S., Gonçalves, D. A., Berni, P. R. D. A., & Teixeira, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823506-5.00002-3 · Cited by 47
Tolerance and nutritional therapy of dietary fibre from konjac glucomannan hydrolysates for patients with inflammatory bowel disease (IBD)
Suwannaporn, P., Thepwong, K., Tester, R. F., Al‐Ghazzewi, F. H., Piggott, J. R., Shen, N., Chen, Z., Chen, F., Yang, J., Zhang, D., et al. (2013) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2013.09.005 · Cited by 45
Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Verbeke, K., Boesmans, L., & Boets, E. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114000639 · Cited by 46
Harvesting of Prebiotic Fructooligosaccharides by Nonbeneficial Human Gut Bacteria
Wang, Z., Tauzin, A. S., Laville, É., Tedesco, P., Létisse, F., Terrapon, N., Lepercq, P., Mercade, M., & Potocki-Véronèse, G. (2020) · mSphere · doi:10.1128/msphere.00771-19 · Cited by 47
Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?
Guandalini, S. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00023 · Cited by 45
Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis
Riwes, M. M., & Reddy, P. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.06.001 · Cited by 44
Diet and Microbiome-Directed Therapy 2.0 for IBD
Ananthakrishnan, A. N., Whelan, K., Allegretti, J. R., & Sokol, H. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.049 · Cited by 43
Production and Extraction of Polysaccharides and Oligosaccharides and Their Use as New Food Additives
Nobre, C., Cerqueira, M. Â., Rodrigues, L. R., Vicente, A. A., & Teixeira, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-63453-5.00021-5 · Cited by 42
Fructan Prebiotics Derived from Inulin
Bosscher, D. (2009) · Springer eBooks · doi:10.1007/978-0-387-79058-9_6 · Cited by 43
Dietary and enteral interventions for Crohn's disease
Yamamoto, T., Shimoyama, T., & Kuriyama, M. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.11.011 · Cited by 41
Prebiotic Enriched Exclusive Enteral Nutrition Suppresses Colitis via Gut Microbiome Modulation and Expansion of Anti-inflammatory T Cells in a Mouse Model of Colitis
Lunken, G., Tsai, K., Schick, A., Lisko, D. J., Cook, L. E., Vallance, B. A., & Jacobson, K. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.06.011 · Cited by 42
Exploring Effects of Chitosan Oligosaccharides on the DSS-Induced Intestinal Barrier Impairment In Vitro and In Vivo
Wang, Y., Wen, R., Liu, D., Zhang, C., Wang, Z. A., & Du, Y. (2021) · Molecules · doi:10.3390/molecules26082199 · Cited by 41
No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis
van der Aa, L. B., Lutter, R., Heymans, H. S. A., Smids, B., Dekker, T., van Aalderen, W. M. C., Smitt, J. H. S., Knippels, L. M. J., Garssen, J., Nauta, A. J., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03890.x · Cited by 41
Healthy effects of prebiotics and their metabolites against intestinal diseases and colorectal cancer
Fernández, J., Redondo-Blanco, S., Miguélez, E. M., Villar, C. J., Clemente, A., & Lombó, F. (2015) · AIMS Microbiology · doi:10.3934/microbiol.2015.1.48 · Cited by 41
The Role of Dietary Fibers in the Management of IBD Symptoms
Rosa, C. D., Altomare, A., Imperia, E., Spiezia, C., Khazrai, Y. M., & Guarino, M. P. L. (2022) · Nutrients · doi:10.3390/nu14224775 · Cited by 44
Techno-Functional Properties and Applications of Inulin in Food Systems
Canazza, E., Grauso, M., Mihaylova, D. S., & Lante, A. (2025) · Gels · doi:10.3390/gels11100829 · Cited by 49
A review: Roles of carbohydrates in human diseases through regulation of imbalanced intestinal microbiota
Cheng, X., Zheng, J., Lin, A., Xia, H., Zhang, Z., Gao, Q., Lv, W., & Liu, H. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104197 · Cited by 44
Isolation, Characterization, and Immunological Effects of α-Galacto-oligosaccharides from a New Source, the Herb Lycopus lucidus Turcz.
Yang, X., Zhao, Y., He, N., & Croft, K. D. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101217f · Cited by 40
Nutritional Modulation of the Inflammatory Bowel Response
Ioannidis, O., Varnalidis, I., Paraskevas, G. K., & Botsios, D. (2011) · Digestion · doi:10.1159/000323456 · Cited by 39
Recipe for IBD: can we use food to control inflammatory bowel disease?
Witkowski, M., Witkowski, M., Gagliani, N., & Huber, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0658-5 · Cited by 39
Study of Enzymatic Hydrolysis of Fructans from Agave salmiana Characterization and Kinetic Assessment
Cuello, C. M., Cerda, I. E. O., Moreno-Vilet, L., Grajales‐Lagunes, A., Moscosa-Santillán, M., Bonnin, J., González‐Chávez, M. M., & Ruiz‐Cabrera, M. A. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/863432 · Cited by 39
Prebiotics and Inflammatory Bowel Disease
Rasmussen, H. E., & Hamaker, B. R. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.08.004 · Cited by 38
Microbiota-independent immunological effects of non-digestible oligosaccharides in the context of inflammatory bowel diseases
Fabbro, S. D., Calder, P. C., & Childs, C. E. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120006953 · Cited by 38
Responses of feeding prebiotics on nutrient digestibility, faecal microbiota composition and short-chain fatty acid concentrations in dogs: a meta-analysis
Patra, A. K. (2011) · animal · doi:10.1017/s1751731111000887 · Cited by 40
Probiotic, Prebiotic and Synbiotic Products in Human Health
Maftei, N.-M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81553 · Cited by 37
Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
Yue, B., Yu, Z., Lv, C., Geng, X., Wang, Z., & Dou, W. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i30.4378 · Cited by 38
The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn’s Disease
Knez, E., Wzorek, K., Folwarski, M., Kaźmierczak-Siedlecka, K., Stachowska, L., Przewłócka, K., Stachowska, E., & Skonieczna‐Żydecka, K. (2021) · Nutrients · doi:10.3390/nu13072125 · Cited by 41
Effects of β-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL/6J mice
Vu, V., Muthuramalingam, K., Singh, V., Hyun, C. L., Kim, Y., Unno, T., & Cho, M. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02668-z · Cited by 37
Synbiotics as Supplemental Therapy for the Alleviation of Chemotherapy-Associated Symptoms in Patients with Solid Tumours
Singh, N., Beckett, J. M., Kalpurath, K., Ishaq, M., Ahmad, T., & Eri, R. D. (2023) · Nutrients · doi:10.3390/nu15071759 · Cited by 49
Antibiotics, Probiotics and Prebiotics in IBD
Bernstein, C. N. (2014) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000360713 · Cited by 39
Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children
Guandalini, S., Cernat, E., & Moscoso, D. I. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0067 · Cited by 38
The Role of Prebiotics in Disease Prevention and Health Promotion
Gyawali, R., Nwamaioha, N., Fiagbor, R., Zimmerman, T., Newman, R. H., & Ibrahim, S. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814468-8.00012-0 · Cited by 37
Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
Healey, G. R., Celiberto, L. S., Lee, S. M., & Jacobson, K. (2020) · Nutrients · doi:10.3390/nu12103204 · Cited by 38
Are all dietary fibers equal for patients with inflammatory bowel disease? A systematic review of randomized controlled trials
Peters, V., Dijkstra, G. D. H., & Campmans-Kuijpers, M. J. E. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab062 · Cited by 38
Assessment of sugars separation from a model carbohydrates solution by nanofiltration using a design of experiments (DoE) methodology
Moreno-Vilet, L., Bonnin-Paris, J., Bostyn, S., Ruiz‐Cabrera, M. A., & Moscosa-Santillán, M. (2014) · Separation and Purification Technology · doi:10.1016/j.seppur.2014.04.040 · Cited by 34
A perspective of intestinal immune-microbiome interactions in alcohol-associated Liver Disease
Bruellman, R. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.53589 · Cited by 35
Reducing Disease Activity of Inflammatory Bowel Disease by Consumption of Plant-Based Foods and Nutrients
Antoniussen, C. S., Rasmussen, H. H., Holst, M., & Lauridsen, C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.733433 · Cited by 37
Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases
Liang, J., Sha, S. M., & Wu, K. (2014) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12211 · Cited by 34
Fructo-oligosaccharides and fibre in enteral nutrition has a beneficial influence on microbiota and gastrointestinal quality of life
Wierdsma, N. J., van Bodegraven, A. A., Uitdehaag, B. M. J., Arjaans, W., Savelkoul, P. H. M., Kruizenga, H. M., & van Bokhorst-de van der Schueren, M. A. E. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520902839675 · Cited by 33
Dietary Polydextrose Prevents Inflammatory Bowel Disease in Trinitrobenzenesulfonic Acid Model of Rat Colitis
Witaicenis, A., Fruet, A. C., Salem, L., & Stasi, L. C. D. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.0275 · Cited by 33
Role of fructooligosaccharides in promoting beneficial gut bacteria: A Prebiotic perspective
Singh, P., Gupta, S., Kundu, A., Grover, M., & Saha, S. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105726 · Cited by 36
Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Naseer, M., Poola, S., Ali, S. A., Samiullah, S., & Tahan, V. (2020) · Current Clinical Pharmacology · doi:10.2174/1574884715666200312100237 · Cited by 33
Low FODMAP Diet for Functional Gastrointestinal Symptoms in Quiescent Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials
Grammatikopoulou, M. G., Goulis, D. G., Gkiouras, K., Nigdelis, M. P., Papageorgiou, S. Τ., Papamitsou, T., Forbes, A., & Bogdanos, D. P. (2020) · Nutrients · doi:10.3390/nu12123648 · Cited by 32
Diet Advice for Crohn’s Disease: FODMAP and Beyond
Popa, S., Pop, C., & Dumitrascu, D. L. (2020) · Nutrients · doi:10.3390/nu12123751 · Cited by 32
Probiotics: Which and When?
Scarpellini, E., Cazzato, A., Lauritano, C., Gabrielli, M., Lupascu, A., Gerardino, L., Abenavoli, L., Petruzzellis, C., Gasbarrini, G., & Gasbarrini, A. (2008) · Digestive Diseases · doi:10.1159/000116776 · Cited by 32
Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics?
Lê, A., Mantel, M., Marchix, J., Bodinier, M., Jan, G., & Rolli‐Derkinderen, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00002.2022 · Cited by 35
Fructooligosaccharides
Chen, G., Li, C., & Chen, K. (2016) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63602-7.00006-0 · Cited by 32
Hygiene, microbial diversity and immune regulation
Guarner, F. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282eeb43b · Cited by 31

Authors: Lindsay, J. O.
Affiliations: Royal London Hospital (GB)
Corresponding author: Lindsay, J O
Venue: Gut
Publisher: BMJ
Published: 2006-03-01
Volume: 55
Issue: 3
Pages: 348-355
ISSN: 0017-5749 (ISSN-L)
DOI: 10.1136/gut.2005.074971
PMC: PMC1856087
OpenAlex: W2164571061
Cited by: 471
References: 55
Citations by year: 2026: 9 · 2025: 19 · 2024: 33 · 2023: 19 · 2022: 35 · 2021: 26 · 2020: 32 · 2019: 20 · 2018: 21 · 2017: 18 · 2016: 21 · 2015: 18 · 2014: 26 · 2013: 21 · 2012: 22
FWCI: 9.56
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Gut (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Research Portal (King's College London) (submittedVersion)
HighWire Press Open Archive (submittedVersion)
UEA Digital Repository (University of East Anglia) (submittedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: fructooligosaccharides, Crohn's disease, Bifidobacterium, dendritic cells, IL-10, TLR2, TLR4, gut microbiota, mucosal immunity, disease activity, prebiotics, rectal mucosa
MeSH terms: Adult, Bifidobacterium, Crohn Disease, Dendritic Cells, Feces, Female, Humans, Intestinal Mucosa, Male, Middle Aged, Oligosaccharides, Patient Compliance, Severity of Illness Index, Immunity, Mucosal, Toll-Like Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks